STRIVERDI RESPIMAT

October 28, 2014November 11, 2015

New COPD Treatment On Display at CHEST 2014 Shows Promise

COPD, News

The results of ANHELTO™ studies evaluating a new treatment for chronic obstructive pulmonary disease were presented by Boehringer Ingelheim (BI) recently at the American College of Chest Physicians (ACCP) 80th ... Read more

October 9, 2014November 11, 2015

Striverdi Respimat Spray for COPD Now Available in U.S. Pharmacies

COPD, News

The inhalation spray Striverdi Respimat (olodaterol), developed by Boehringer Ingelheim, is now available in U.S. pharmacies. The 5 mcg spray is a long-term, once-daily maintenance bronchodilator therapy for airflow obstruction caused by ... Read more

August 7, 2014November 11, 2015

Boehringer Ingelheim’s Striverdi Respimat (olodaterol) Inhalation Spray for COPD Maintenance Gets FDA Approval

COPD, News

The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim’s Striverdi® Respimat® (olodaterol) Inhalation Spray 5 µg to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic ... Read more